2-methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole
Structure Info
- Chemspace ID
- CSSB00010144810 (In-Stock Building Blocks)
- MFCD
- MFCD18384930
- IUPAC Name
- 2-methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole
- Mol formula
- C15H19BN2O3
- Mol weight
- 286 Da
- Catalog Number(s)
- 1119090-20-8, 40305, 244037, A019132016, A348941, A40305, AA00HC49, ACM1119090208, AG00HC71, AG229053, AI08757, AR00HCW1, ArZ-UP111209, BBLS00010144810, BBV-78425075, BD493077, BS-30110, CD11350726, CS-0176937, CSC010144810, FCH2801146, HY-W119775, JH62218, JM-14B-002, LAN-B58558, LN04597043, M340233, ST00HDNT, TX00HDCP, UUB09020, Y1237187, Y4315780, ZX-AE050910, ZXC174333, a6_29343_98042, bbls00010144810
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.94
- Heavy atoms count
- 21
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.466
- Polar surface area (Å)
- 57
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSB00010144810
Items Overall 40 items from 10 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific CN | 3 days | China To: | 97 | 250 mg | 94.60 | |
| 1st Scientific CN | 3 days | China To: | 97 | 1 g | 191.40 | |
| 1st Scientific CN | 3 days | China To: | 97 | 5 g | 687.50 | |
| 1st Scientific CN | 3 days | China To: | 97 | 10 g | 1,111.00 | |
| 1st Scientific CN | 3 days | China To: | 97 | 25 g | 2,202.20 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| 1st Scientific LLC | 3 days | United States To: | 97 | 250 mg | 94.60 | |
| 1st Scientific LLC | 3 days | United States To: | 97 | 1 g | 191.40 | |
| 1st Scientific LLC | 3 days | United States To: | 97 | 5 g | 687.50 | |
| 1st Scientific LLC | 3 days | United States To: | 97 | 10 g | 1,111.00 | |
| 1st Scientific LLC | 3 days | United States To: | 97 | 25 g | 2,202.20 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| Angene US | 10 days | United States To: | 97 | 250 mg | 85.50 | |
| Angene US | 10 days | United States To: | 97 | 1 g | 188.10 | |
| Angene US | 10 days | United States To: | 97 | 5 g | 715.50 | |
| Angene US | 10 days | United States To: | 97 | 10 g | 1,165.50 | |
| Angene US | 10 days | United States To: | 97 | 25 g | 2,323.80 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| A2B Chem | 12 days | United States To: | 97 | 250 mg | 77.05 | |
| A2B Chem | 12 days | United States To: | 97 | 500 mg | 97.75 | |
| A2B Chem | 12 days | United States To: | 97 | 1 g | 170.20 | |
| A2B Chem | 12 days | United States To: | 97 | 5 g | 748.65 | |
| A2B Chem | 12 days | United States To: | 97 | 10 g | 1,219.00 | |
| A2B Chem | 12 days | United States To: | 97 | 25 g | 2,431.10 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| AA BLOCKS | 12 days | United States To: | 97 | 250 mg | 90.20 | |
| AA BLOCKS | 12 days | United States To: | 97 | 1 g | 146.30 | |
| AA BLOCKS | 12 days | United States To: | 97 | 10 g | 1,230.90 | |
| AA BLOCKS | 12 days | United States To: | 97 | 25 g | 2,454.10 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| AOBChem CN | 12 days | China To: | 95 | 1 g | 130.90 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| AOBChem USA | 12 days | United States To: | 95 | 1 g | 130.90 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| BB4LS GS | 15 days | Latvia To: | 97 | 50 umol | 64.15 | |
| BB4LS GS | 15 days | Latvia To: | 97 | 100 umol | 65.34 | |
| BB4LS GS | 15 days | Latvia To: | 97 | 200 umol | 66.53 | |
| BB4LS GS | 15 days | Latvia To: | 97 | 300 umol | 67.72 | |
| BB4LS GS | 15 days | Latvia To: | 97 | 500 umol | 68.90 | |
| eNovation CN | 20 days | China To: | 95 | 250 mg | 115.00 | |
| eNovation CN | 20 days | China To: | 95 | 5 g | 793.50 | |
| eNovation CN | 20 days | China To: | 95 | 10 g | 1,293.75 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
| 10X CHEM | TBD | United States To: | 97 | 250 mg | 66.00 | |
| 10X CHEM | TBD | United States To: | 97 | 1 g | 154.00 | |
| 10X CHEM | TBD | United States To: | 97 | 5 g | 605.00 | |
| 10X CHEM | TBD | United States To: | 97 | 10 g | 990.00 | |
| 10X CHEM | TBD | United States To: | 97 | 25 g | 1,981.10 | |
Description: 2-Methyl-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole; CAS: 1119090-20-8 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 2-methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010144811](/st/structure/200/8c3ddbce958b5166652338b9aa5b6d09/CC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of [3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]boronic acid - CSSB00000049293](/st/structure/200/688aff54fbc1321926d9e9208a2124f2/CC1%253DNN%253DC%2528O1%2529C1%253DCC%253DCC%2528%253DC1%2529B%2528O%2529O.png)
![Chemical structure of 5-methyl-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2,4-oxadiazole - CSSB00010090726](/st/structure/200/93334c74a146c9ce99e547f48a01a424/CC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 2-methyl-5-{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1,3,4-oxadiazole - CSSB00010270277](/st/structure/200/c20ab74c91c210fee7418d3c40fddefc/CC1%253DNN%253DC%2528CC2%253DCC%253DCC%2528%253DC2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529O1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole - CSSB00010082543](/st/structure/200/29f6e0136a0a0e60951312cfcbefdbd9/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%253DCO1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010144809](/st/structure/200/493e98023a91f6d044789a829f1f6afd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2H-1,2,3,4-tetrazole - CSSB00010286267](/st/structure/200/8976e9e4d7863e02933a2102ab445500/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNNN%253DN1.png)
